Perspectives on RUNX genes: An update

American Journal of Medical Genetics, Part A

Volumn 149, Issue 12, 2009, Pages 2629-2646

  Cohen Jr , M Michael ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

BMP; CBF ; CD4; CD8; Cleidocranial dysplasia; Cohesin; Collagenase 3; Dominant negative effect; Downstream targets; Endochondral bone formation; Evolution; Familial platelet disorder acute myelogenous leukemia; Familial thrombocytopenia; Functional osteoblasts; Gastric adenocarcinoma; Haploinsufficiency; Hematopoiesis; Histone deacetylase 4; Immune function; Intramembranous bone formation; Isoforms; Osterix; Pre osteoblasts; Promoters; RUNK3; Runt domain; RUNX1; RUNX2; TGF ; Transactivation domain

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CD4 ANTIGEN; CD8 ANTIGEN; COHESIN; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR RUNX3; TRANSFORMING GROWTH FACTOR BETA;

ACUTE GRANULOCYTIC LEUKEMIA; ALLELE; CD8+ T LYMPHOCYTE; CLEIDOCRANIAL DYSPLASIA; CYTOTOXIC T LYMPHOCYTE; EPIGENETICS; EXON; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENE SEQUENCE; GENE SILENCING; GENE TARGETING; GENETIC TRANSCRIPTION; HEMATOPOIESIS; HUMAN; MISSENSE MUTATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; REVIEW; STOMACH ADENOCARCINOMA; THROMBOCYTOPENIA; THYMOCYTE; TRANSACTIVATION; TUMOR SUPPRESSOR GENE;

ANIMALS; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DISEASE; EVOLUTION, MOLECULAR; HEMATOPOIESIS; HUMANS; IMMUNE SYSTEM; MUTATION;

INVERTEBRATA; VERTEBRATA;

EID: 71949088306     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.33021     Document Type: Review

References (87)

1. Å berg T, Cavender A, Gaikwad JS, Bronckers ALJJ, Wang X, Waltimo-Sirén J, Thesleff I, D'Souza RN. 2004. Phenoypic changes in dentition of Runx2 homozygote-null mutant mice. J Histochem Cytochem 52:131-138.
2. Bangsow C, Rubins N, Glusman G, Bernstein Y, Negreanu V, Goldenberg D, Lotem J, Ben-Asher E, Lancet D, Levanson D, Groner Y. 2001. The RUNX3 gene-Sequence, structure and regulated expression. Gene 279: 221-232. (Pubitemid 33132184)
3. Bergwitz C, Prochnau A, Mayr B, Kramer FJ, Rittierodt M, Berten HL, Hausamen JE, Brabarnt G. 2001. Identification of novel CBFA1/RUNX2 mutations causing cleidocranial dysplasia. J Inherit Metab Dis 24: 648-656. (Pubitemid 33130086)
4. Blialek P, Kern B, Yang X, Schrock M, Sosic D, Hong N, Wu H, Yu K, Ornitz DM, Olson EN, Justice MJ, Karsenty G. 2004. A Twist code determines the onset of osteoblast differentiation. Dev Cell 6:423-435. (Pubitemid 38364573)
5. Blyth K, Terry A, MacKay N, Vaillant F, Bell M, Cameron ER, Neil JC, Stewart M. 2001. Runx2: A novel oncogenic effector revealed by in vitro complementation and retroviral tagging. Oncogene 20:295-302. (Pubitemid 32142318)
6. Cameron ER, Neil JC. 2004. The Runx genes: Lineage-specific oncogenes and tumor suppressors. Oncogene 23:4308-4314. (Pubitemid 38758596)
7. Chen AI, de Nooij JC, Jessell TM. 2006a. Graded activity of transcription factor Runx3 specifies the laminar termination pattern of sensory axons in the developing spine. Neuron 49:395-408.
8. Chen C-L, Broom DC, Liu Y, de Nooij JC, Zhe L, Cen C, Samad OA, Jessel TM, Woolf CJ, Ma Q. 2006b. Runx1 determines nociceptive sensory neuron phenotype and is required for thermal and neuropathic pain. Neuron 49:365-377. (Pubitemid 43152239)
9. Choi J-Y, Pratap J, Javed A, Zaidi SK, Xing L, Balint E, Dalamangas S, Boyce B, van Wijnen AJ, Lian JB, Stein JL, Jones SN, Stein GS. 2001. Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic Development. Proc Natl Acad Sci USA 97:10549-10554. (Pubitemid 32678082)
10. Cohen MM Jr. 2001. RUNX genes, neoplasia, and cleidocranial dysplasia. Am J Med Genet 104:185-188.
11. Cohen MM Jr. 2003. TGFβ/Smad signaling system and its pathologic correlates. Am J Med Genet Part A 116A:1-10.
12. Cohen MM Jr. 2006. The new bone biology: Pathologic, molecular, and clinical correlates. Am J Med Genet Part A 140A:2646-2706.
13. Committee on Human Leukocyte Differentiation Antigens, IUIS WHO Nomenclature. 1984. Proposed nomenclature for human leukocyte differentiation antigens. Bull WHO 5:809-811.
14. de Bruijn MFTR, Speck NA. 2004. Core-binding factors in hematopoiesis and immune function. Oncogene 23:4238-4248.
15. Dickey-Sims C, Robertson AJ, Rupp DE, McCarthy JJ, Coffman JA. 2005. Runx-dependent expression of PKC is critical for cell survival in the sea urchin embryo. BMC Biol 3:18-29. (Pubitemid 41534966)
16. Durst KL, Hiebert SW. 2004. Role of RUNX family in transcriptional repression and gene silencing. Oncogene 23:4220-4224.
17. Enomoto H, Enomoto-Iwamoto M, Iwamoto M, Nomura S, Himeno M, Kitamura Y, Kishimoto T, Komori T. 2000. Cbfa1 is a positive regulatory factor in chondrocyte maturation. J Biol Chem 275:8695-8702. (Pubitemid 30180221)
18. Fang J, Hall BK. 1997. Chondrogenic cell differentiation from membrane bone periostea. Anat Embryol 196:349-362. (Pubitemid 27489959)
19. Fonseca P, Lee B, Napierala D. 2008. RUNX2 and cleidocranial dysplasia. In: Epstein CJ, Erickson RP, Wynshaw-Boris A, editors. Inborn Errors of Development. 2nd edition. New York: Oxford University Press. Ch. 36, pp 399-405.
20. Fukamachi H, Ito K. 2004. Growth regulation of gastric epithelial cells by Runx3. Oncogene 23:4330-4335. (Pubitemid 38758598)
21. Galler KM, Yasue A, Cavender AC, Bialek P, Karsenty G, D'Souza RN. 2007. A novel role for Twist-1 in Pulp homeostasis. J Dent Res 86:951-955.
22. Gamou T, Kitamura E, Hosoda F, Shimizu K, Shinohara K, Hayashi Y, Nagase T, Yokoyama Y, Ohki M. 1998. The partner gene of AML1 in t(16;21) myeloid malignancies is a novel member of the MTG8 (ETO) family. Blood 91:4028-4037. (Pubitemid 28261962)
23. Geoffroy V, Kneissel M, Fournier B, Boyde A, Mathias P. 2002. High bone resorption in adul aging transgenic mice over-expressing cbfa/runx2 in cells of osteoblastic lineage. Mol Cell Biol 22:6222-6233. (Pubitemid 34857841)
24. Grigoriadis AE, Heersche JN, Aubin JE. 1988. Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: Effect of dexamethasone. J Cell Biol 106: 2139-2151.
25. Hall BK. 2005. Bones and Cartilage: Development and Evolutionary Skeletal Biology. San Diego: Elsevier.
26. Hecht J, Stricker S, Wiecha U, Stiege A, Panopoulou G, Podsiadlowski L, Poustka AJ, Dieterich C, Ehrich S, Suvorova J, Mundlos S, Seitz V. 2008. Evolution of a core gene network for skeletogenesis in Chordates. PLos Genet 4:e1000025.
27. Horsfield JA, Anagnostou SH, Kuang-Hsien J, Hsiao K, Cho Y, Geisler R, Lieschke G, Crosier KE, Crosier PS. 2007. Cohesin-dependent regulation of Runx genes. Development 134:2639-2649.
28. Huang L-F, Fukal N, Selby PB, Olsen BR, Mundlos S. 1997. Mouse clavicular development: Analysis of wild type and cleidocranial dysplasia mutant mice. Dev Dyn 210:33-40. (Pubitemid 27371931)
29. Ito Y. 1999. Molecular basis of tissue-specific gene expression mediated by the Runt domain transcription factor PEBP2/CBF. Genes Cells 4: 685-696. (Pubitemid 30053316)
30. Ito Y. 2004. Oncogenic potential of the RUNX gene family: 'Overview'. Oncogene 23:4198-4208.
31. Ito Y, Bae S-C. 1997. The runt domain transcription factor, PEBP2/CBF, and its involvement in human leukemia. In: Karen M, editor. Progress in gene expression. Basal, Switzerland: Birkhäuser Verlag. pp 107-132.
32. Ito Y, Miyazono K. 2003. Runx transcription factors as key targets of TGF-β superfamily signaling. Curr Opin Genet Dev 13:43-47. (Pubitemid 36143926)
33. Izumi K, Yahagi N, Fujii Y, Higuchi M, Kosaki R, Naito Y, Nishimura G, Hosokai N, Takahashi T, Kosaki K. 2006. Cleidocranial dysplasia plus vascular anomalies with 6p21.2 microdeletion spanning RUNX2 and VEGF. Am J Med Genet Part A 140A:398-401. (Pubitemid 43227657)
34. Jiménez MJ, Balbin M, Lopez JM, Alvarez J, Komori T, Lopez-Otin C. 1999. Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation. Mol Cell Biol 19:4431-4442. (Pubitemid 29242017)
35. Karsenty G. 1999. The genetic transformation of bone biology. Genes Dev 13:3037-3051.
36. Komori T, Kishimoto T. 1998. Cbfa1 in bone development. Curr Opin Genet Dev 8:494-499.
37. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao Y-H, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T. 1997. Targeted disruption of cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764. (Pubitemid 27516178)
38. Kramer I, Sigrist M, de Nooij JC, Taniuchi I, Jessell TM, Arber S. 2006. A role for Runx transcription factor signalling in dorsal root ganglion sensory neuron diversification. Neuron 49:379-393. (Pubitemid 43152240)
39. Krantz ID, McCallum J, DeScipio C, Kaur M, Gillis LA, Yaeger D, Jukofsky L, Wasserman N, Bottani A, Morris CA. 2004. Cornelia de Lange syndrome is caused by mutations in NIPBL, the human homolog of Drosophila melanogaster Nipped-B. Nat Genet 36:631-635. (Pubitemid 38715992)
40. Kundu M, Javed A, Jeon J-P, Horner A, Shum L, Eckhaus M, Muenke M, Lian JB, Yang Y, Nuckolls GH, Stein GS, Liu PP. 2002. Cbfbeta interacts with Runx2 and has a critical role in bone development. Nat Genet 32:639-644.
41. Lee B, Zhou G. 2004. RUNX2 and cleidocranial dysplasia. In: Epstein CJ, Erickson RP, Wynshaw-Boris A, editors. Inborn Errors of Development. 1st edition. New York: Oxford University Press. Ch. 29, pp 331-339.
42. Lee MTM, Tsai AC-H, Chou C-H, Sun F-M, Huang L-C, Yen P, Lin C-C, Liu C-Y, Wu J-Y, Chen Y-T, Tsai F-J. 2008. Intragenic microdeletion of RUNX2 is a novel mechanism for cleidocranial dysplasia. Genomic Med 2:45-49.
43. Levanon D, Groner Y. 2004. Structure and regulated expression of mammalian RUNX genes. Oncogene 23:4211-4219. (Pubitemid 38758586)
44. Levanon D, Brenner O, Negreanu V, Bettoun D, Woolf E, Eilam R, Lotem J, Gat U, Otto F, Speck N, Groner Y. 2001. Spatial and temporal expression pattern of Runx3 (Aml12) and Runx1 (Aml1) indicates non-redundant functions during mouse embryogenesis. Mech Dev 109:413-417. (Pubitemid 33112059)
45. Li Q-L, Ito K, Sakakura C, Fukamachi H, Inoue K-I, Chi X-Z, Lee C-W, Han S-B, Kim H-M, Kim W-J, Yamamoto H, Yamashita N, Yano T, Ikeda T, Itohara S, Inazawa J, Abe T, Hagiwara A, Yamagishi H, Ooe A, Kaneda A, Sugimura T, Ushijima T, Bae S-C, Ito Y. 2002. Causal relationship between loss of RUNX3 expression and gastric cancer. Cell 109:113-124. (Pubitemid 34327521)
46. Liu H, Carlsson L, Grundström T. 2006. Identification of an N-terminal transactivation domain that separates molecular function from global differentiation function. J Biol Chem 281:25659-25669. (Pubitemid 44401955)
47. Look AT. 1997. Oncogenic transcription factors in the human acute leukemias. Science 278:1059-1064. (Pubitemid 27517875)
48. Lou Y, Javed A, Hussain S, Colby J, Frederick D, Pratap J, Xie R, Gaur T, van Wijnen AJ, Jones SN, Stein GS, Lian JB, Stein JL. 2009. ARunx2 threshold for the cleidocranial dysplasia phenotype. Hum Mol Genet 18:556-568.
49. McLarren KW, Lo R, Grbavec D, Thirunavukkarasu K, Karsenty G, Stifani S. 2000. The mammalian basic helix loop helix protein HES-1 binds and modulates the transactivation function of the runt-related factor Cbfa1. J Biol Chem 275:530-538. (Pubitemid 30039015)
50. Merks JHM, Caron HN, Hennekam RCM. 2005. High incidence of malformation syndromes in a series of 1,073 children with cancer. Am J Med Genet Part A 134A:132-143.
51. Minelli A, Maserati E, Rossi G, Bernardo ME, De Stefano P, Cecchini MP, Valli R, Albano V, Pierani P, Leszi A, Sainati L, Lo Curto F, Danesino C, Locatelli F, Pasquali F. 2004. Familial platelet disorder with a propensity to acute myelogenous leukemia: Genetic heterogeneity and progression to leukemia via acquisition of clonal chromosome anomalies. Genes Chromosomes Cancer 40:165-171. (Pubitemid 38703094)
52. Miyazono K, Maeda S, Imamura T. 2004. Coordinate regulation of cell growth and differentiation by TGF-β superfamily and Runx proteins. Oncogene 23:4232-4237. (Pubitemid 38758589)
53. Mundlos S. 1999. Cleidocranial dysplasia: Clinical and molecular genetics. J Med Genet 36:177-182. (Pubitemid 29110444)
54. Mundlos A, Otto F, Mundlos C, Mulliken JB, Aylsworth AS, Albright S, Lindhout D, Cole WG, Henn W, Knoll JHM, Owen MJ, Mertelsmann R, Zabel BU, Olsen BR. 1997. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89:773-779. (Pubitemid 27516180)
55. Musio A, Selicorni A, Focarelli ML, Gervasini C, Milani D, Russo S, Vezzoni P, Larzza L. 2006. X-linked Cornelia de Lange syndrome owing to SMC1L1 mutations. Nat Genet 38:528-530.
56. Nakashima K, de Crombrugghe B. 2003. Transcriptional mechanisms in osteoblast differentiation and bone formation. Trends Genet 19: 458-466. (Pubitemid 36930029)
57. Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B. 2002. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108:17-29. (Pubitemid 34137009)
58. Neil J, Cameron E, Stewart M, Blyth K, Vaillant F, Ming H, Terry A, Mackay N, Bell B. 2000. In vivo and in vitro analysis of Cbfa1/Runx2 oncogenic functions. International Workshop on Runt-Domain Transcription Factors, Kyoto, Japan, July 17-20.
59. Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing JR. 1996. AML1, the target of multiple chromosomal translocation in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84: 321-330. (Pubitemid 26042836)
60. OMIM 190685. 2007. Down syndrome (Online Mendelian Inheritance in Man).
61. Osato M. 2004. Point mutations in the RUNX1/AML1 gene: Another actor in RUNX leukemia. Oncogene 23:4284-4296. (Pubitemid 38765137)
62. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GWH, Beddington RSP, Mundlos S, Olsen BR, Selby PB, Owen MJ. 1997. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89: 765-771. (Pubitemid 27516179)
63. Otto F, Lübbert M, Stock M. 2003. Upstream and downstream targets of RUNX proteins. J Cell Biochem 89:9-18. (Pubitemid 36459094)
64. Pozner A, Lotem J, Xiao C, Goldenberg D, Brenner O, Negreanu V, Levanson D, Groner Y. 2007. Developmentally regulated promobmc ter switch transcriptionally controls Runx1 function during embryonic hematopoiesis. BMC Dev Biol 7:84-101. (Pubitemid 47245247)
65. Quack I, Vonderstrass B, Stock M, Aylsworth AS, Becker A, Brueton L, Lee PJ, Mejewski F, Mulliken JB, Suri M, Zenker M, Mundlos S, Otto F. 1999. Mutation analysis of core binding factor CBFA1 in patients with cleidocranial dysplasia. Am J Hum Genet 65:1268-1278. (Pubitemid 30460377)
66. Rennert J, Coffman JA, Mushegian AR, Robertson AJ. 2003. The evolution of Runx genes. I. Acomparative study of sequences from phylogenetically diverse model organisms. BMC Evol Biol 3:4-12.
67. Rodan GA, Harada S. 1997. The missing bone. Cell 89:677-680.
68. Sato T, Ohno S-I, Hayashi T, Sato C, Kohu K, Satake M, Habu S. 2005. Dual functions of Runx proteins for reactivating CD8 and silencing CD4 at the commitment process into CD8 thymocytes. Immunity 22:317-328. (Pubitemid 40387474)
69. Shin HD, Jeon J-P, Park BL, Bae JS, Nam H-Y, Shin S-M, Park KS, Han B-G. 2008. Novel promoter polymorphism in RUNX2 is associated with serum triglyceride level. Mol Cells 26:459-461.
70. Song W-J, Sullivan MG, Legare RD, Hutchings S, Tsn X, Kufrin D, Ratajczak J, Resende IC, Haworth C, Hock R, Loh M, Felix C, Roy DC, Busque L, Kurnit D, Willman C, Gewirtz AM, Speck NA, Bushweller JH, Li FP, Gardiner K, Poncz M, Maris JM. 1999. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet 23:166-175. (Pubitemid 29455388)
71. Stein GS, Lian JB, van Wijnen AJ, Stein JL, Montecino M, Javad A, Zaidi SK, Young DW, Choi J-Y, Pockwinse SM. 2004. Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression. Oncogene 23:4315-4329. (Pubitemid 38758597)
72. Taketani T, Taka T, Takita J, Ono R, Horikoshi Y, Kaneko Y, Sako M, Hanada R, Hongo T, Hayashi Y. 2002. Mutation of the AM1/RUNX1 gene in a transient myeloproliferative disorder patient with Down syndrome. Leukemia 16:1866-1867. (Pubitemid 35050122)
73. Taniuchi I, Littman DR. 2004. Epigenetic silencing by Runx proteins. Oncogene 23:4341-4345.
74. 1 exon of Runx2 encoding a novel proline-rich C-terminal domain. Gene 336:115-125.
75. Thirunavukkarasu K, Mahajan M, McLarren KW, Stifani S, Karsenty G. 1998. Two domains unique to osteoblast-specific transcription factor Osf2/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbfbeta. Mol Cell Biol 18:4197-4208. (Pubitemid 28287943)
76. Tintut Y, Parharni F, Li V, Karsenty G, Demer LL. 1999. Inhibition of osteoblast-specific transcription factor Cbfa1 by the cAMP pathway in osteoblastic cells. Ubiquitin/proteasome-dependent regulation. J Biol Chem 274:28875-28879. (Pubitemid 29477039)
77. Van Wijnen AJ, Stein GS, Gergen JP, Groner Y, Hiebert SW, Ito Y, Liu P, Neil JC, Ohki M, Speck N. 2004. Nomenclature for Runt-related (RUNX) proteins. Oncogene 23:4209-4210.
78. Vega RB, Matsuda K, Oh J, Barbosa AC, Yang X, Meadows E, McAnally J, Pomajzl C, Shelton JM, Richardson JA, Karsenty G, Olson EN. 2004. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 119:555-566. (Pubitemid 39482354)
79. Williams LJ, Lester T, Beaumont HJ, Crocker M, Noakes C, Stefanidou A, Sarri C, Bazopoulou-Kyrkanidou E, Seller A, Petersen MB, Wilkie AOM. 2005. A novel case of craniosynostosis caused by a 6p21 duplication that includes the entire RUNX2 gene. J Med Genet 42:S106.
80. Woolf E, Xiao C, Fainaru O, Lotem J, Rosen D, Negreanu V, Bernstein Y, Goldenberg D, Brenner O, Berke G, Levanon D, Groner Y. 2003. Runx3 and Runx1 are required for CD8 T cell development during thymopoiesis. Pre Natl Acad Sci USA 100:7731-7736. (Pubitemid 36760038)
81. Xiao G, Jiang D, Gopalakrishnan R, Franceschi RT. 2002. Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1/Runx2. J Biol Chem 277:36181-36187.
82. Yamashiro T, Åberg T, Levanon D, Groner Y, Thesleff I. 2002. Expression of Runx1, -2, and -3 during tooth, palate and craniofacial bone development. Gene Expr Patterns 2:109-112. (Pubitemid 36356023)
83. Yamashiro T, Wang X-P, Zhe L, Oya S,Åberg T, Fukunaga T, Kamioka H, Specj NA, Takano-Yamamoto T, Thesleff I. 2004. Possible roles of Runxl and Sox9 in incipient intramembranous ossification. J Bone Miner Res 19:1671-1677.
84. Yoshida CA, Furuichi T, Fujita T, Fukayama R, Kanatani N, Kobayashi S, Satake M, Takada K, Komori T. 2002. Core-binding factor beta interacts with Runx2 and is required for skeletal development. Nat Genet 32:633-638. (Pubitemid 35435176)
85. Yoshida CA, Yamamoto H, Fujita T, Furuichi T, Ito K, Inoue K-I, Yamana K, Zanma A, Takada K, Ito Y, Komori T. 2004. Runx2 and Runx3 are essential for chondrocyte maturation, and Runx2 regulates limb growth through induction of Indian hedgehog. Genes Dev 18:952-963. (Pubitemid 38529663)
86. Zhong J, Pevny L, Snider WD. 2006. "Runx"ing towards sensory differentiation. Neuron 49:325-327.
87. Zhou G, Chen Y, Zhou L, Thirunavukkarasu K, Hecht J, Chitayat D, Gelb BD, Pirinen S, Berry SA, Greenberg CR. 1999. CBFA1 mutation analysis and functional correlation with phenotypic variability in cleidocranial dysplasia. Hum Mol Genet 8:2311-2316. (Pubitemid 29525347)